Last mentioned: Mar 24, 2026
Program Expansion
Expected rollout of enhanced digital post-transplant monitoring for the patient cohort.
Consolidation Phase
Manipal integrates Columbia Asia and AMRI Hospitals into its network.
IPO Filing
Manipal Health officially files draft papers for an $852 million public listing in India.
Milestone Announcement
Manipal Hospital Yeshwanthpur officially announces the 500+ transplant achievement.
World Kidney Day
Global awareness day focusing on kidney health and transplant access.
Clinical Review
Scheduled publication of long-term outcomes for the 50 ABOi transplant cases.
Temasek Acquisition
Temasek acquires a majority stake in Manipal Health, valuing the firm at $5 billion.
Manipal Health Enterprises has officially filed its Draft Red Herring Prospectus (DRHP) with SEBI, marking a significant milestone for the Temasek-backed hospital chain. The IPO is expected to be one of the largest in the Indian healthcare sector, providing a partial exit for institutional investors while fueling further expansion.
Manipal Health Enterprises has filed its Draft Red Herring Prospectus for a landmark $1 billion initial public offering. The move marks a significant milestone for the Temasek-backed hospital chain, positioning it to capitalize on India's surging demand for private healthcare infrastructure.
Manipal Health Enterprises has officially filed its Draft Red Herring Prospectus (DRHP) for an initial public offering, marking a pivotal moment for India's second-largest hospital chain. The move follows years of aggressive consolidation and a majority stake acquisition by Singapore’s Temasek.
Manipal Health Enterprises, India's second-largest hospital chain, has filed for an $852 million initial public offering, marking a major exit opportunity for majority shareholder Temasek. The filing comes amid a surge in Indian equity markets and growing investor appetite for scaled healthcare infrastructure.
Manipal Hospital Yeshwanthpur has reached a significant clinical milestone, completing over 500 kidney transplants, including 50 complex ABO-incompatible procedures. This achievement underscores the hospital's leadership in high-acuity nephrology and the expanding capabilities of India's tertiary healthcare sector.